Medications affecting the IGF-1/Growth Hormone Axis, including teprotumumab, somatostatin analogues and anti-CGRP monoclonal antibodies, are associated with an elevated reporting odds of alopecia in women; a pharmacovigilance study.
-
アブストラクト ジャーナル名 Journal of the American Academy of Dermatology 投稿日 2023/4/17 投稿者 Jedlowski, Patrick M; Jedlowski, Mahdieh F; Fazel, Mohammad 組織名 University of Arizona College of Medicine - Tucson, Division of Dermatology,;Tucson, AZ, USA. Electronic address: pjedlowski@email.arizona.edu.;Tucson, AZ, USA. Pubmed リンク https://www.ncbi.nlm.nih.gov/pubmed/37062463/ -
お問合わせ
検索
メルマガ登録
